X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

VOX SANGUINIS

期刊標題檢索 VOX SANG 最新評論: The title of a paper should be concise and not too long. With the prem... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[VOX SANGUINIS]您好,您是該頁面的第 16347 位訪客。

期刊簡介
期刊名稱VOX SANGUINIS VOX SANGUINIS
LetPub Score
5.2
50 ratings
Rate

Reputation
6.3

Influence
3.9

Speed
7.0

期刊簡稱VOX SANG
ISSN0042-9007
E-ISSN1423-0410
h-index77
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.400.6990.839
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Hematology
Q257 / 137

自引率 (2023-2024)11.10%自引率趨勢
掲載範囲
Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections:

1) Transfusion - Transmitted Disease and its Prevention:

Identification and epidemiology of infectious agents transmissible by blood;

Bacterial contamination of blood components;

Donor recruitment and selection methods;

Pathogen inactivation.

2) Blood Component Collection and Production:

Blood collection methods and devices (including apheresis);

Plasma fractionation techniques and plasma derivatives;

Preparation of labile blood components;

Inventory management;

Hematopoietic progenitor cell collection and storage;

Collection and storage of tissues;

Quality management and good manufacturing practice;

Automation and information technology.

3) Transfusion Medicine and New Therapies:

Transfusion thresholds and audits;

Haemovigilance;

Clinical trials regarding appropriate haemotherapy;

Non-infectious adverse affects of transfusion;

Therapeutic apheresis;

Support of transplant patients;

Gene therapy and immunotherapy.

4) Immunohaematology and Immunogenetics:

Autoimmunity in haematology;

Alloimmunity of blood;

Pre-transfusion testing;

Immunodiagnostics;

Immunobiology;

Complement in immunohaematology;

Blood typing reagents;

Genetic markers of blood cells and serum proteins: polymorphisms and function;

Genetic markers and disease;

Parentage testing and forensic immunohaematology.

5) Cellular Therapy:

Cell-based therapies;

Stem cell sources;

Stem cell processing and storage;

Stem cell products;

Stem cell plasticity;

Regenerative medicine with cells;

Cellular immunotherapy;

Molecular therapy;

Gene therapy.
官方網站http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1423-0410
在線稿件提交http://mc.manuscriptcentral.com/vox
開放訪問No
出版商Wiley-Blackwell Publishing Ltd
主題領域医学
出版國/地區ENGLAND
發行頻率隔月刊行
創刊年1953
每年文章數129每年文章數趨勢
黃金OA百分比18.40%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
HEMATOLOGYSCIEQ366/97
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0042-9007%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【VOX SANGUINIS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal of Hematology & OncologyH-index: 60

    CiteScore: 48.10
    BLOODH-index: 426

    CiteScore: 23.60
    LEUKEMIAH-index: 176

    CiteScore: 18.10
    AMERICAN JOURNAL OF HEMATOLOGYH-index: 92

    CiteScore: 15.70
    HAEMATOLOGICAH-index: 125

    CiteScore: 14.10
    BLOOD REVIEWSH-index: 85

    CiteScore: 13.80
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGYH-index: 111

    CiteScore: 11.00
    BRITISH JOURNAL OF HAEMATOLOGYH-index: 172

    CiteScore: 8.60
    SEMINARS IN HEMATOLOGYH-index: 88

    CiteScore: 6.20
    HEMATOLOGICAL ONCOLOGYH-index: 42

    CiteScore: 4.20
    學科內最受檢索的期刊 頁面查看次數
    BLOOD111250
    Journal of Hematology & Oncology101410
    LEUKEMIA58326
    BRITISH JOURNAL OF HAEMATOLOGY51135
    LEUKEMIA & LYMPHOMA44611
    Hematology37553
    ANNALS OF HEMATOLOGY36345
    AMERICAN JOURNAL OF HEMATOLOGY35538
    LEUKEMIA RESEARCH34229
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY33041
  •  

    VOX SANGUINIS VOX SANGUINIS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [VOX SANGUINIS] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:34:26 評論於
The title of a paper should be concise and not too long. With the premise of accurately reflecting and clearly expressing the most important specific content, fewer words are better, try to avoid unnecessary words, and delete redundant words as much as possible. Short paper titles generally have a higher citation rate
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:07:43 評論於
I have been studying Japanese for one year and I am slowly getting better at speaking and writing
(0) 讚! | 维尔娜菲茨杰拉德

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 17:26:39 評論於
What to Do When the Article Title is Too Long?
(0) 讚! | 龙鳞孝礼

作者: Oswald Edie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 17:10:48 評論於
How many words are generally required for an article title?
(0) 讚! | Oswald Edie

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 20:22:54 評論於
Too brutal! It dropped so much, who dares to invest in the future again??
(0) 讚! | 凌霄高洁

作者: Susie Jenny


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-05-19 19:43:23 評論於
Submitted on May 18th, with submission number 130
(0) 讚! | Susie Jenny

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-11-28 19:37:41 評論於
Can we make it to the top 3 next year? Let's discuss
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 15:24:54 評論於
Bullish, there is a possibility to break through 3 points if it continues to rise tomorrow
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [VOX SANGUINIS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*